# The Role of the Unbinding Cycle on the Coordination Abilities of the Bi-Cyclopeptides toward Cu(II) Ions

**Authors:** Alicja Lisowska, Paulina Świątek, Filip Dębicki, Agnieszka Lewińska, Aleksandra Marciniak, Lorenzo Pacini, Anna Maria Papini, Justyna Brasuń

PMC · DOI: 10.3390/molecules29102197 · 2024-05-08

## TL;DR

This study explores how the structure of bi-cyclopeptides affects their ability to bind Cu(II) ions, revealing insights into their coordination behavior.

## Contribution

The paper introduces new insights into how the unbinding cycle in bi-cyclopeptides influences their coordination abilities toward Cu(II) ions.

## Key findings

- Bicyclic structures enhance the involvement of imidazole donors in Cu(II) binding.
- The position of histidine residues affects the coordination of amide donors in monocyclic analogues.
- Structural differences significantly influence Cu(II) coordination abilities in bi-cyclopeptides.

## Abstract

Bicyclic peptides have attracted the interest of pharmaceutical companies because of their remarkable properties, putting them on a new path in medicine. Their conformational rigidity improves proteolytic stability and leads to rapid penetration into tissues via any possible route of administration. Moreover, elimination of renal metabolism is of great importance, for example, for people with a history of liver diseases. In addition, each ring can function independently, making bicyclic peptides extremely versatile molecules for further optimization. In this paper, we compared the potentiometric and spectroscopic properties studied by UV–vis, MCD, and EPR of four synthetic analogues of the bi-cyclic peptide c(PKKHP-c(CFWKTC)-PKKH) (BCL). In particular, we correlated the structural and spectral properties of complexes with coordinating abilities toward Cu(II) ions of MCL1 (Ac-PKKHPc(CFWKTC)PKKH-NH2) that contains the unbinding cycle and N- and C-terminal linear parts with two histidine residues, one per part; two monocyclic ligands containing one histidine residue, both in the N-terminal position, i.e., MCL2 (Ac-PKKHPc(CFWKTC)PKKS-NH2) and in the C-terminal position, i.e., MCL3 (Ac-PKKSPc(CFWKTC)PKKH-NH2), respectively; and the linear structure LNL (Ac-PKKHPSFWKTSPKKH-NH2). Potentiometric results have shown that the bicyclic structure promotes the involvement of the side chain imidazole donors in Cu(II) binding. On the other hand, the results obtained for the mono-cyclic analogues lead to the conclusion that the coordination of the histidine moiety as an anchoring group is promoted by its location in the peptide sequence further from the nonbinding cycle, strongly influencing the involvement of the amide donors in Cu(II) coordination.

## Full-text entities

- **Genes:** MCL1 (MCL1 apoptosis regulator, BCL2 family member) [NCBI Gene 4170] {aka BCL2L3, EAT, MCL1-ES, MCL1L, MCL1S, Mcl-1}
- **Diseases:** liver diseases (MESH:D008107)
- **Chemicals:** imidazole (MESH:C029899), Bi-Cyclopeptides (-), amide (MESH:D000577), histidine (MESH:D006639)

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11124368/full.md

---
Source: https://tomesphere.com/paper/PMC11124368